ARWR

#873
Arrowhead Pharmaceuticals, Inc. - Common Stock
77.3 5 USD
-2.15%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
76.65
77.37
Year Range
0.74
82.00
Daily Change
-2.15%
Monthly Change
+8.56%
6 month change
+47.81%
Year Change
+97.83%
Previous Close
79.0 5
Open
76.8 1
Low
76.6 5
High
77.3 7
Volume
429
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 10.9 B
  • Employee 711
  • Founded 2004
  • CEO Christopher Richard Anzalone
  • Website www.arrowheadpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRVKH0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-30.14
Price to sales ratio
13.9

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

News